Skip to main content

A behavioral design approach to improving a Chagas disease vector control campaign in Peru



Individual behavior change is a critical ingredient in efforts to improve global health. Central to the focus on behavior has been a growing understanding of how the human brain makes decisions, from motivations and mindsets to unconscious biases and cognitive shortcuts. Recent work in the field of behavioral economics and related fields has contributed to a rich menu of insights and principles that can be engineered into global health programs to increase impact and reach. However, there is little research on the process of designing and testing interventions informed by behavioral insights.


In a study focused on increasing household participation in a Chagas disease vector control campaign in Arequipa, Peru, we applied Datta and Mullainathan’s “behavioral design” approach to formulate and test specific interventions. In this Technical Advance article we describe the behavioral design approach in detail, including the Define, Diagnosis, Design, and Test phases. We also show how the interventions designed through the behavioral design process were adapted for a pragmatic randomized controlled field trial.


The behavioral design framework provided a systematic methodology for defining the behavior of interest, diagnosing reasons for household reluctance or refusal to participate, designing interventions to address actionable bottlenecks, and then testing those interventions in a rigorous counterfactual context. Behavioral design offered us a broader range of strategies and approaches than are typically used in vector control campaigns.


Careful attention to how behavioral design may affect internal and external validity of evaluations and the scalability of interventions is needed going forward. We recommend behavioral design as a useful complement to other intervention design and evaluation approaches in global health programs.

Peer Review reports


Individual behavior change is a critical ingredient in efforts to improve global health. While improving access to high quality health services and strengthening health systems capacity have been important foci of global health and development initiatives, in recent decades the “behavioral revolution” has focused attention on how individual behavior and decision-making drive the effectiveness of most global health programs [1, 2]. Effective, evidence-based interventions for infectious disease prevention—e.g., child vaccination, bed nets, HIV treatment regimens—often fail at the last mile due to individual and household decisions, habits, and behaviors [1, 2]. As countries undergo rapid demographic and nutritional transitions [3, 4], the role of behaviors in driving chronic disease risk is further amplified [5].

Central to the focus on behavior has been a growing understanding of how the human brain makes decisions, from motivations and mindsets to unconscious biases and cognitive shortcuts that we all use to simplify a complex world that demands attention and focus [6, 7]. Recent work in the field of behavioral economics and related fields has contributed a rich menu of insights, principles, empirical regularities and strategies that can be engineered into global health programs to attempt to increase impact and reach [8].

For example, present bias, the tendency to place more weight on costs and benefits realized today and less weight on those realized in the future, makes us prioritize immediate pleasure over actions that are in our long-term interest [9, 10]. Correctly-designed financial incentives can leverage present bias by offering immediate, tangible rewards for current health-related behaviors that may be tedious, unpleasant, or otherwise costly. Loss aversion, the tendency to value losses more highly than gains of the same face value, makes us hold onto assets that we might not be willing to pay for again [11]. An incentive structure that endows participants with up-front resources that are forfeited if behavioral targets are not met leverages loss aversion to increase impact.

In parallel with the behavioral revolution, other important trends are transforming global health research and practice. Interest is growing among the global policy community in the power (and limitations) of randomized controlled trials (RCTs) to evaluate the impact of health and development interventions—the so-called “evaluation revolution” [12]. In the past decade, many RCTs of innovative interventions informed by behavioral insights have been funded and fielded, generating policy-relevant evidence to inform future investments in global health programs. Finally, the “design for development” movement has expanded the global health practitioner’s toolkit with new ways to think about innovation, idea generation, user-defined needs, and user experience [13,14,15].

Datta & Mullainathan [12] and others [16] have identified a systematic “behavioral design” approach to leveraging the potential of behavioral economics insights into health and development programs. Their framework calls for a four-step process that begins well before the design and evaluation of behaviorally-informed interventions. In theory, a rigorous approach to intervention design should improve the effectiveness of public and private-sector health programs. However, the feasibility of behavioral design as a method for global health research remains unknown. We present here our application of behavioral design to a door-to-door Chagas disease vector control campaign in Arequipa, Peru. We begin with an explanation of the campaign context and the motivation to intervene to improve household participation. Next, we describe the design phases of the study. We report both our original intervention designs as they emerged from the design process, as well as modifications that had to be made to the designs during the Test phase (a pragmatic field trial). Lastly, we discuss lessons learned for future research projects and programs using behavioral design.

Study context: Chagas disease vector control campaign in Arequipa, Peru

Chagas disease has the highest parasitic disease burden in the Americas [17], with an estimated 8 million infected with Trypanosoma cruzi, the etiologic agent of the disease [17, 18]. T. cruzi is transmitted via contact with the feces of infected triatomine bugs, which harbor the parasite in their guts. Infections have a 20–30% probability of eventually progressing to cardiac or digestive forms of chronic Chagas disease, which are difficult to treat and often fatal [19].

Since 1991, Triatoma infestans, the principal insect vector of T. cruzi in southern South America, has been the target of an elimination program known as the Southern Cone Initiative [20]. As a result, three countries (Chile [21], Brazil [22], and Uruguay [23]) have been declared free of T. cruzi transmission by T. infestans. However, the transmission of T. cruzi by T. infestans remained common in the city of Arequipa, Peru until recently [24]. In some periurban communities of this city, more than 5% of children were infected with T. cruzi prior to control activities [25].

Since 2003 the Peruvian Ministry of Health (MOH) has been engaged in Chagas disease vector control in urban Arequipa (population 650,000). The campaign consists of three phases: a preliminary entomological survey to determine which areas will be covered in the campaign; an “attack” phase in which all households targeted for control measures are sprayed with insecticide (usually Deltamethrin) a total of two times at six-month intervals (referred to as Cycle 1 and Cycle 2); and an ongoing period of active and passive surveillance for vector re-emergence. The attack phase also includes community-wide promotion; the extent and nature of the promotion has varied over time as budgets fluctuated. When a specific locality (neighborhood) is scheduled for spraying, houses are first visited by a health promoter one day prior to spraying to inform them about the campaign and how to prepare their home for the insecticide application (large furniture moved away from walls, food and dishes put away, beddings and clothes put away). Ideally, during this visit the promoter also confirms the household’s willingness to have the home sprayed, and schedules this for the following day at an approximate time (e.g., 8 am, 10 am, 12 pm). Due to frequent no-shows and an unpredictable spray schedule, the promoters overschedule each time slot.

On the day of treatment, the health promoter returns to the house to “open” it: ensuring that a household member is home to open the house to the sprayers and confirming that preparations have been made and that sufficient water supply is available to mix the insecticide solution to the correct concentration. The sprayer arrives and spends 1–2 h spraying the home (depending on the size of the house). Following treatment, household members are asked to ventilate the house for 2–3 h.

As the campaign proceeds, several data elements are collected for all households in campaign areas. During the preliminary entomological survey, data are collected on household infestation and the presence of animals and animal corrals in the house and peridomicile. During the attack phase, infestation data are updated, and promoters and the spray brigades record the ultimate campaign outcome for each household or property scheduled for spray: treated (sprayed), refused, closed (meaning promoters and campaign staff were never able to speak to someone who lives in the house), and uninhabited, vacant, or public/commercial property (typically not treated during the campaign).

Recently, the vector control campaign in Arequipa has suffered from declining rates of participation, threatening efforts to eliminate vector-borne Chagas disease [26] and ultimately the success of the Southern Cone Initiative. Given the low participation rates in the spray campaign in the Mariano Melgar district of Arequipa in 2012–2013, there was mutual interest between the Ministry of Health and our research team in increasing household participation in future efforts in other districts. We adopted a behavioral design framework to guide these efforts. Following formative and pilot work [27, 28] and an initial grant submission (2011–2013), the project was awarded a five-year extramural grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development in early 2014 (R01HD075869).


Datta & Mullainathan’s [12] behavioral design approach comprises a four-step process that begins well before the design and evaluation of behaviorally-informed interventions (see Fig. 1 in Datta & Mullainathan). Similar to a product design or engineering process, behavioral design starts with problem definition: what are you trying to fix, and why? Next, a diagnosis phase identifies “actionable bottlenecks” or possible targets of intervention where psychological factors are driving behavior. Only then do the investigators proceed to intervention design, matching behavioral insights to actionable bottlenecks. In the final step, these interventions are tested, ideally in a randomized controlled counterfactual evaluation complemented by a factual evaluation of mechanisms, implementation, and participant experience [29].

Problem definition

Problem definition drives problem solution [30]. This relationship has important and often overlooked implications for intervention design. Problem definition can be specific to the local context. Problems that are amendable to the behavioral design process are typically related to end-user behaviors (vs. upstream structural barriers), assume a pre-determined solution, and have the potential to significantly improve well-being [31]. The problem definition step is complex for Chagas disease. Definitions of success for the control of Chagas disease have shifted over the years and in some ways the existing vector control campaign functions as a pre-determined solution. We generated and evaluated several possible problem definition statements, and iteratively reviewed with stakeholders and investigators until consensus was reached. The agreed-upon problem definition is reported below in Results.

Behavioral diagnosis

Various methods were applied to diagnose the problem. As part of the larger parent study, we analyzed participation and survey data collected by the Ministry of Health in the first round of spraying in one district (n = 2911 households) [28]. We conducted focus group discussions (2 groups with total of 17 participants) and semi-structured interviews (n = 71) with household members in campaign areas in March and May 2013 respectively, in a district where a spray campaign had taken place 1 year earlier [27]. We also relied on knowledge gained in more than a decade of working with MOH on the vector-control campaign. With these multiple rich sources of data, we distilled specific insights about psychological factors that were shaping bottlenecks to our target behavior (see Results section below).

Intervention design

Following the diagnosis phase, we engaged in an iterative process of grouping actionable bottlenecks together into coherent bundles, and then looking to the existing literature on the application of specific behavioral economic principles to generate intervention designs that could address those bottlenecks. Design work was done collaboratively with stakeholders from many disciplines (e.g., economics, epidemiology, ecology, behavioral science) and perspectives (e.g., researchers, health ministry managers, campaign fieldstaff). As intervention ideas were formulated, some rapid-cycle pilot testing to assess feasibility, acceptability, and effectiveness was done.

Intervention trial

A cluster-randomized controlled trial was designed and carried out in the Alto Selva Alegre district of Arequipa during the Cycle 2 treatment in March–October 2015 [32]. We divided the spray area into 56 clusters of approximately 80–100 households. Clusters were randomly assigned to a control arm or to one of the three intervention arms, with assignment balanced by prior vector infestation and household participation in a preliminary entomological survey. The sample size in each arm was approximately 1400 households. All households in the sampled sectors were included in the trial.

The primary outcome in the cluster-randomized trial was participation rate by intervention arm in an intent-to-treat (ITT) analysis. The study was powered to compare the relative effectiveness of each intervention to the control (current campaign) and to each of the other interventions. We also planned analyses of secondary outcomes including treatment intensity (number of visits from promoters and sprayers needed to achieve participation) and a per protocol analysis of participation by intervention arm (including only those households which received the intervention).


Problem definition

Multiple candidate problem definition statements emerged including the elimination of the insect vector from the study area, or seroprevalence of T. cruzi infection in children 5 or younger of below 1%, the keystone of the current WHO/PAHO definition of disruption of vectorial transmission [33]. We also considered the proportion of houses sprayed with insecticide in the spray campaign, a number with important epidemiologic and programmatic significance. However, the problem that seemed most compelling and salient, both for our research and for the success of the campaign going forward, was at an individual level: household members were choosing not to participate in the campaign.

Behavioral diagnosis

Analysis of prior campaign data revealed geographic clustering of participants along blocks. Specifically, the odds of participating in spraying doubled if one had a neighbor who participated, controlling for socioeconomic status and prior infestation (both of which are spatially correlated) [28]. Although the spatial clustering we observed does not imply that one’s neighbors influence the decision to participate or not in a spray campaign, it does suggest that there may be an element of social contagion [28]. Spray campaign refusers were also asked for a motive for their refusal. The most common reason was that they could not wait for the sprayers because of work obligations, followed by concerns about side-effects of the insecticide (i.e., allergies, asthma triggers) [28].

Focus groups and interviews revealed multiple barriers to participation: inconvenient spray times due to work obligations; the difficulty of preparing homes for spraying (e.g., moving heavy furniture); lack of trust in sprayers (e.g., concern about theft or about sprayers assessing property value to increase taxes); secondary health impacts (e.g., allergic reactions to insecticides); aversion to the odor of the insecticide; lack of ventilation within the home; low perceived Chagas disease risk and perceived need to spray; stained walls; and the inconvenience of waiting outside during insecticide application [27]. As suggested in our prior analysis [28], we also found that most household decision-makers consulted other family members about their decisions to spray the home, and slightly more than half talked to a neighbor about it.

We gleaned additional insights through analysis of several important structural, political, and financing factors that have influenced the design and implementation of the local campaign since its initiation. In the early years, the campaign received technical support from the Pan American Health Organization (PAHO) and financial support from the Canadian International Development Agency (CIDA) [34]. This support allowed for significant investments in campaign promotion via radio ads and murals. In 2002, Peru’s Ley Orgánica de los Gobiernos Regionales transferred numerous functions, including many related to health, to regional governments [35]. The transfer was completed in 2006. Around this time the funding for the campaign was diverted from one regional office (the regional office of the Ministry of Health) to another (the Red de Salud Arequipa-Caylloma). A gap in funding in 2009 prevented the purchase of insecticide and paused the campaign [36, 37]. The bulk of the campaign promotion is now carried out through megaphoning and household visits. Over time, the geographic focus of the campaign has shifted from primarily poor, recently established communities (pueblos jovenes) to districts with greater economic and social heterogeneity. Vector infestation patterns are also more heterogeneous in the more urban districts [38,39,40]. Participation in poorer neighborhoods is generally higher than in wealthier and more established areas of the city.

The results of the behavioral diagnosis phase were summarized in a set of actionable bottlenecks or barriers to our desired outcome (household participation in the vector control campaign). These bottlenecks were linked to specific behavioral economics constructs (see Table 1), and eventually to intervention designs.

Table 1 Mapping of bottlenecks to behavioral-economics principles and interventions

Intervention designs

After several design iterations, three interventions emerged: 1) advanced planning; 2) block leader recruitment; and 3) contingent group lotteries (see Table 1). The design process unfolded over the course of submitting and resubmitting an extramural grant proposal to fund the study. During the design process we frequently consulted with our field staff, partners at the Ministry of Health (MOH) in Arequipa, and behavioral economics experts. Brief descriptions of each intervention follow. Tables 2, 3 and 4 provide considerably more detail on rationale, bottlenecks addressed, behavioral economic principles applied, and evolution of each intervention from original design to implemented version.

Table 2 Advanced planning intervention: Diagnosis and Design
Table 3 Block leader recruitment intervention: Diagnosis and Design
Table 4 Contingent group lotteries intervention: Diagnosis and Design

Advanced planning (see Table 2)

To address challenges in both scheduling treatment at a convenient time and getting the home ready for treatment, this intervention leveraged present bias and planning prompts to encourage households to schedule the spray well in advance, and to make a plan based on this commitment. In coordination with the existing MOH campaign, households were approached 7–10 days in advance and asked to commit to participate. Households that agreed to participate were offered convenient 2h appointment windows on their preferred future spray date. A refrigerator magnet with blank spaces to note appointment time and preparation plans was also offered as a planning prompt. In addition, households were given the opportunity to request a phone call or in-person reminder prior to their scheduled appointment. This intervention required additional spray staff to accommodate schedules more tailored and responsive to household requests than in previous campaigns.

Block leader recruitment (see Table 3)

To address low awareness of neighbors’ participation in the campaign and potential distrust of government campaign staff, this intervention recruited formal and informal community leaders to promote participation and persuade reluctant neighbors. Two to 4 weeks prior to targeted spray dates, campaign staff approached community members who would be known to most people in the neighborhood and asked them to recruit their neighbors to participate in the campaign. These block leaders included both formal community leaders (MOH-trained health promoters, block captains, and elected community officials) and informal neighborhood opinion leaders (corner store owners, daycare coordinators),. Leaders attended training sessions where they were provided with campaign t-shirts, clipboards, mobile airtime cards, and campaign promotional literature. Recruiters were assigned 10–12 households on their block to visit and promote the campaign. This intervention required additional time to recruit, train, and follow-up with leaders, and additional resources to purchase t-shirts, phone cards, and supplies and refreshments for training sessions. The intervention also relied on volunteer time from leaders.

Contingent group lotteries (see Table 4)

To address the time and hassle costs of campaign participation, and to encourage communication with neighbors about the campaign, this intervention used contingent group lotteries to reward households for agreeing to participate in the spray campaign. Contiguous households along block faces were assigned to lottery groups of 5–7 households; each group was randomly assigned one lottery number and a specific national lottery drawing date 2–6 weeks in the future. If a group’s number was drawn in the national lottery, households that had participated in the campaign received a voucher for a local hardware store (value PEN 50, $17 at the time of the study). If all of the households in the group had participated, each household received a larger voucher (PEN 100, $34). This intervention required additional staff to promote the lottery during the campaign, and additional resources to purchase and distribute vouchers to winning households.

Feasibility and acceptability of intervention designs were confirmed through rapid-cycle pilots and conversations with Ministry of Health staff. In addition, components of several of the proposed interventions had been tested in prior research undertaken by the team. For example, we had previously piloted narrow-window scheduling and neighbor recruitment during previous campaign phases in four other communities in Arequipa. In this pilot we were able to achieve a participation rate of 92%. Communities had not, however, been randomly assigned to this intervention and were outside the city in an area that may be more open to public health interventions. In terms of prior testing of contingent group lotteries, our team included a leading expert in the use of lotteries for health behavior change. The lottery proposed in our study was adapted directly from a successfully lottery study led by this expert. We also knew from substantial experience in our field site that raffles are commonplace and well-understood in Peru, and are regularly conducted to raise money for schools, cover medical costs, etc.

Over the course of our design phase, there were many interventions that were considered but then rejected for various reasons. The financial incentives arm in particular generated many possible formats and structures for design and delivery of incentives. In the past, district governments have threatened fines for non-participation; to our knowledge, however, these fines have rarely, if ever, been collected. We therefore thought fines would be neither credible nor appropriate. Other suggestions emerging from our analysis that were not within the purview of our project included giving government employees a day off from work to have their houses sprayed, increasing the “opt out” burden of refusal (i.e., requiring households to get a permit to not spray), coordinating with the municipality to give a 10% reduction in local taxes for participating, and changing the insecticide formulation to reduce safety concerns.

Intervention trial

Implementation of designed interventions

In the behavioral design approach, interventions are designed based on identifying actionable bottlenecks and applying behavioral insights to address those bottlenecks. Testing these “idealized” interventions in the field may require adaptations to increase feasibility and acceptability. Unexpected events may also change intervention feasibility. While we had pilot-tested most components of the interventions in earlier studies, our interventions also required real-time modifications in the early phase of the field trial. In Tables 2, 3 and 4 we describe in detail the motivations for and content of the most important and substantive modifications. The pragmatic nature of this trial (i.e. accompanying an existing, ongoing Ministry of Health campaign) required a nimble, responsive approach to intervention implementation, while balancing the critical need for rigor and fidelity in adhering to our study design.

Intervention efficacy

The results from this trial are reported in detail elsewhere [41]. Briefly, Cycle 2 participation was high (over 80%) in the study area, with little difference across study arms (see Fig. 1). There was a suggestion of lower participation in the block leader recruitment arm compared with advanced planning and group lotteries in an intent-to-treat sample and lower participation compared with all other arms in a per protocol sample. We assessed two measured of campaign “efficiency”: First, we evaluated whether advanced planning reduced the duration of treatment, given that houses should have been better prepared for treatment. Second, we assessed whether any of the interventions persuaded households to participate after just one campaign visit vs. requiring additional visits during "catch-up" periods. We did not see improved efficiency along either of these dimensions. Finally, a post-hoc assessment of Cycle 2 participation among households who had refused treatment in Cycle 1 revealed significantly higher odds of participation in the advanced planning treatment arm compared with control households.

Fig. 1

Percentage of households participating in insecticide treatment during Cycle 2 of attack-phase Chagas-disease vector-control campaign, Arequipa, Peru, 2015, by treatment arm and analytic sample. See Buttenheim et al. 2018 for more details


Our research team is focused on a specific health-related behavior: participation in a government-run insecticide spray campaign to interrupt the vectorial transmission of Chagas disease, a vector-borne parasitic disease. While we were interested in applying principles from behavioral economics to address participation challenges, we were reluctant to show up with a behavioral economics hammer in search of some intervention nails. The behavioral design framework discussed here [12] provided a systematic methodology for defining the behaviors of interest, diagnosing reasons for household reluctance or refusal to participate, designing interventions to address actionable bottlenecks, and then testing those intervention in a rigorous counterfactual context. Behavioral design offered us a broader range of strategies and approaches than pure price changes and community education and health promotion.

Of course, we have to note that the results from our cluster randomized trial of almost 5000 households showed no significant increases in participation for our behaviorally-designed interventions compared to the control campaign [41]. We discuss possible reasons for this finding elsewhere [41], but are reluctant to infer from this one trial that the behavioral design approach is ineffective. The pragmatic, real-world setting of our study made the behavioral design approach challenging, productive, and focused. Behavioral design challenged us to do more—and more different—types of formative work than we had previously conducted in Arequipa around the Chagas campaign. The approach also demanded a new level of collaboration and integration with our partners in the Ministry of Health in order to rethink both the vector control campaign design and implementation processes. We argue that behavioral design was ultimately productive in uncovering previously unstudied explanations for household reluctance and refusal to participate in the campaign, while also keeping the intervention design focused on addressing key actionable bottlenecks rather than letting fashionable or conceptually interesting behavioral insights drive that process. We found that the complexity of an ongoing public health campaign, the interdisciplinary composition of our team, and a long candidate list of compelling and potentially relevant behavioral insights to apply in this setting required a framework that could organize and focus our work in an efficient and transdisciplinary way.

We are not the first team to employ a behavioral design approach in empirical studies. The Datta and Mullainathan framework has been applied to interventions in the agricultural [42], financial services [43,44,45,46,47,48], WASH (water, sanitation and hygiene) [49, 50] and global health [16, 51] sectors. In addition, numerous governments (although few in developing countries) have instituted “nudge units” or “behavioral insights teams” to bring a behavioral perspective to policy design and implementation [52,53,54]. It will be important, but challenging, to evaluate the marginal impact of behavioral design on program effectiveness and implementation. One potential evaluation strategy would be random assignment of behavioral design approaches across multiple organizations or sites that are developing and rolling out similar interventions.

An important question going forward is the impact of employing a behavioral design approach on internal and external validity of global health research. In our case behavioral design led to more complex interventions that addressed multiple actionable bottlenecks and employed multiple behavioral insights. Increasingly complex interventions can make interpretation and inference challenging and can make treatment fidelity hard to assess in the field. The implicit pragmatic focus of behavioral design also means that interventions developed through this process are often being deployed in real-world settings where tight control of intervention and sampling is not possible, thereby also undermining internal validity.

Behavioral design can also hinder external validity by tailoring interventions so precisely to the local context through identified actionable bottlenecks that results have limited generalizability to other settings. In our case it is unlikely that the interventions we designed, even if shown to dramatically improve participation in Arequipa’s vector control campaign, would be useful in the same form in another South American Chagas campaign or, for example, in a bed bug elimination campaign in a major US city. This tension is of course not new to the design and evaluation of global health programs and is a key theme in the evaluation revolution. Behavioral design’s contribution to generalizability may therefore lie in the process itself: The define-diagnose-design-test steps can be implemented in virtually any setting for any behaviors of interest, and, if applied rigorously, can expand the use of relevant behavioral insights to solve persistent health challenges.

A related question is how behavioral design approaches may impact scalability of interventions. Scalability refers to the ability to expand successful interventions to a broader population or larger scale [55]. Key dimensions of scalability include cost, workforce to carry out the intervention with fidelity, and interaction of the intervention with contextual factors. Our experience using behavioral design to “supercharge” an existing government-run vector control campaign has convinced us that the approach is a powerful facilitator of scalability, by encouraging strategic tailoring of large-scale interventions to local context. The definition and diagnoses phases of behavioral design can also help to identify the lowest common denominator or minimum effective dose of an intervention prior to scale.


We applied behavioral design, a four-phase approach to intervention development and evaluation, to the problem of declining household participation in a Chagas disease vector-control campaign in Arequipa, Peru. The approach helped us link problem definition and formative work on diagnosis of actionable bottlenecks to the design and testing of interventions informed by behavioral insights. While we did not follow the prescription to the letter, the framework provided useful guidance. Careful attention to how behavioral design may affect internal and external validity of evaluations, and scalability of interventions, is needed going forward. We recommend behavioral design as a useful complement to other intervention design and evaluation approaches in global health programs.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.



Canadian International Development Agency


Human Immunodeficiency Virus




Ministry of Health


Pan American Health Organization


Randomized controlled trial


World Health Organization


  1. 1.

    The World Bank. World development report 2015: mind, society, and behavior. 2015; Accessed 1 Feb 2017.

    Google Scholar 

  2. 2.

    Stansfield SK, Walsh J, Prata N, Evans T. Information to improve decision making for health. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington (DC): The International Bank for Reconstruction and Development / The World Bank Group; Oxford University press; 2008. p. 1017–30.

    Google Scholar 

  3. 3.

    Bongaarts J. Human population growth and the demographic transition. Philos Trans R Soc Lond B. 2009;364(1532):2985–90.

    Article  Google Scholar 

  4. 4.

    Amuna P, Zotor FB. Epidemiological and nutrition transition in developing countries: impact on human health and development. Proc Nutr Soc. 2008;67(1):82–90.

    Article  Google Scholar 

  5. 5.

    McGinnis JM. Actual causes of death, 1990–2010. Workshop on determinants of premature mortality. Washington, DC: National Research Council; 2013.

    Google Scholar 

  6. 6.

    Tversky A, Kahnemann D. Judgment under uncertainty: heuristics and biases. Utility, probability, and human decision making. Science. 1974;11:141–62.

    Google Scholar 

  7. 7.

    De Martino B, Kumaran D, Seymour B, Dolan RJ. Frames, biases, and rational decision-making in the human brain. Science. 2006;313(5787):684–7.

    Article  Google Scholar 

  8. 8.

    Volpp KG, Asch DA. Making the healthy choice the easy choice: using behavioral economics to advance a culture of health. QJM. 2016;110:271–5 1hcw190.

    PubMed Central  Google Scholar 

  9. 9.

    O’Donoghue T, Rabin M. Doing it now or later. Am Econ Rev. 1999;89(1):103–24.

    Article  Google Scholar 

  10. 10.

    Frederick S, Loewenstein G, O’donoghue T. Time discounting and time preference: a critical review. J Econ Lit. 2002;40(2):351–401.

    Article  Google Scholar 

  11. 11.

    Kahneman D, Knetsch JL, Thaler RH. Anomalies: the endowment effect, loss aversion, and status quo bias. J Econ Perspect. 1991;5(1):193–206.

    Article  Google Scholar 

  12. 12.

    Datta S, Mullainathan S. Behavioral design: a new approach to development policy. Rev Income Wealth. 2014;60(1):7–35.

    Article  Google Scholar 

  13. 13.

    Oosterlaken I. Design for Development: a capability approach. Des Issues. 2009;25(4):91–102.

    Article  Google Scholar 

  14. 14.

    Medhi I. User-centered design for development. Interactions. 2007;14(4):12–4.

    Article  Google Scholar 

  15. 15.

    Simpson R. Design for development: a review of emerging methodologies. Dev Pract. 2007;17(2):220–30.

    Article  Google Scholar 

  16. 16.

    Luoto J, Carman KG. Behavioral economics guidelines with applications for health interventions. Washington DC: Inter-American Development Bank; 2014.

  17. 17.

    World Health Organization. Global health estimates 2014 summary tables: DALY by cause, age and sex by WHO region, 2000–2012. 2014; Accessed 7 Feb 2017.

    Google Scholar 

  18. 18.

    Romanha AJ, Castro SL, Soeiro MNC, et al. In vitro and in vivo experimental models for drug screening and development for Chagas disease. Mem I Oswaldo Cruz. 2010;105(2):233–8.

    CAS  Article  Google Scholar 

  19. 19.

    Bern C. Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med. 2011;364(26):2527–34.

    CAS  Article  Google Scholar 

  20. 20.

    Dias JC. Southern cone initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation, and perspectives. Mem Inst Oswaldo Cruz. 2007;30(102):11–8.

    Article  Google Scholar 

  21. 21.

    Lorca M, García A, Contreras MC, Schenone H, Rojas A. Evaluation of a Triatoma infestans elimination program by the decrease of Trypanosoma cruzi infection frequency in children younger than 10 years, Chile, 1991-1998. Am J Trop Med Hyg. 2001;65(6):861–4.

    CAS  Article  Google Scholar 

  22. 22.

    Silveira A, Vinhaes MC. Elimination of vector-borne transmission of Chagas disease. Mem Inst Oswaldo Cruz. 1999;94(Suppl 1):405–11.

    Article  Google Scholar 

  23. 23.

    Elimination of transmission of Chagas disease in southernmost Latin America. World Health Forum 1994;15(3):299–300.

  24. 24.

    Levy MZ, Bowman N, Kawai V, et al. Periurban Trypanosoma cruzi-infected Triatoma infestans in Arequipa, Peru. Emerg Infect Dis. 2006;12(9):1345–52.

    Article  Google Scholar 

  25. 25.

    Levy MZ, Kawai V, Bowman NM, et al. Targeted screening strategies to detect Trypanosoma cruzi infection in children. PLoS Negl Trop Dis. 2007;1(3):e103.

    Article  Google Scholar 

  26. 26.

    Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gürtler RE. The challenges of Chagas disease—grim outlook or glimmer of hope? PLoS Med. 2007;4(12):e332.

    Article  Google Scholar 

  27. 27.

    Paz-Soldan VA, Bauer K, Hunter GC, et al. To spray or not to spray? Understanding participation in an indoor residual spray campaign in Arequipa, Peru. Glob Public Health. 2018;13(1):65–82.

    Article  Google Scholar 

  28. 28.

    Buttenheim AM, Paz-Soldan V, Barbu C, et al. Is participation contagious? Evidence from a household vector control campaign in urban Peru. J Epidemiol Community Health. 2014;68(2):103–9.

    Article  Google Scholar 

  29. 29.

    White H. Impact evaluation: the experience of World Bank’s independent evaluation group. MPRA Paper No. 1111. 2006; Accessed 7 Feb 2017.

    Google Scholar 

  30. 30.

    Buede DM, Miller WD. The engineering design of systems: models and methods. 3rd ed: Wiley; 2016.

  31. 31.

    Fiorillo A, Potok L, Wright J, Peachey J, Davies K. Applying behavioral economics to improve microsavings outcomes. 2014. Paper presented at: Ideas.

    Google Scholar 

  32. 32.

    Buttenheim A, Levy MZ, Paz Soldan VA. Improving participation in door-to-door vector control campaigns using behavioral economics (AEA RCT registry). 2015; Accessed 7 Feb 2017.

    Google Scholar 

  33. 33.

    PAHO. Informe de un grupo de estudio sobre estrategias de control de la enfermedad de chagas / Group study report on chagas’ disease control. Washington, D.C: Estudio sobre Estrategias de Control de la Enfermedad de Chagas; 1987.

    Google Scholar 

  34. 34.

    Project profile: Prevention and Control of Communicable Diseases. 2016; Accessed 7 Feb 2017.

    Google Scholar 

  35. 35.

    Ley N. 27867-Ley Orgánica De Gobiernos Regionales. Boletín Oficial El Peruano. 2003.

  36. 36.

    Alcalde-Rabanal JE, Lazo-González O, Nigenda G. Sistema de salud de Perú. SciELO Analytics. 2011;53(2):12.

    Google Scholar 

  37. 37.

    Calvo-Gonzalez O, Apostolou A, Aviles AM, et al. The decentralization process and its links with public expenditure efficiency. Washington DC: World Bank; 2010. p. 115.

  38. 38.

    Barbu CM, Hong A, Manne JM, et al. The effects of city streets on an urban disease vector. PLoS Comput Biol. 2013;9(1):e1002801.

    CAS  Article  Google Scholar 

  39. 39.

    Hong AE, Barbu CM, Small DS, Levy MZ. Mapping the spatial distribution of a disease-transmitting insect in the presence of surveillance error and missing data. J R Stat Soc A Stat Soc. 2014;178(3):641–58.

    Article  Google Scholar 

  40. 40.

    Levy MZ, Barbu CM, Castillo-Neyra R, et al. Urbanization, land tenure security and vector-borne Chagas disease. Proc Biol Sci 2014;281:20141003.

    Article  Google Scholar 

  41. 41.

    Buttenheim AM, Paz-Soldán VA, Castillo-Neyra R, et al. Increasing participation in a vector control campaign: a cluster randomised controlled evaluation of behavioural economic interventions in Peru. BMJ Glob Health. 2018;3(5):e000757.

    Article  Google Scholar 

  42. 42.

    Travis EM. The impact of text messages on adoption and knowledge of integrated Pest management practices: a randomized control trial study of potato farmers in Carchi. Ecuador: Virginia Polytechnic Institute and State University; 2015.

    Google Scholar 

  43. 43.

    Asis MG, Woolcock M. Operationalizing the science of delivery agenda to enhance development results. Washington DC: World Bank Group; 2015.

    Google Scholar 

  44. 44.

    Labie M, Laureti C, Szafarz A. Discipline and flexibility: a behavioral perspective on product Design in Microfinance. Brussels: Universite Libre de Bruxelles 2015; 2016. p. 36.

  45. 45.

    Camacho A, Cunningham W, Rigolini J, Silva V. Addressing access and behavioral constraints through social intermediation services: a review of Chile Solidario and red Unidos. Washington DC: World Bank; 2014.

    Google Scholar 

  46. 46.

    Elabed G, Carter MR. Compound-risk aversion, ambiguity and the demand for microinsurance. J Econ Behav Organ. 2015;118:37.

    Article  Google Scholar 

  47. 47.

    Kowalski J. Prize-linked savings products: an innovative tool for increasing savings among low-income households? Public Sphere. 2015;19:131–49.

    Google Scholar 

  48. 48.

    Jang CAW. Essays in development and behavioral economics. Honolulu: University of Hawaii at Manoa; 2014.

    Google Scholar 

  49. 49.

    Coville A, Orozco V. Moving from efficacy to effectiveness: using behavioural economics to improve the impact of WASH interventions. Waterlines. 2014;33(1):8.

    Article  Google Scholar 

  50. 50.

    Datta S, Miranda JJ, Zoratto L. Saving water with a nudge (or two): evidence from Costa Rica on the effectiveness and limits of low-cost behavioral interventions on water Use1; 2015.

    Google Scholar 

  51. 51.

    Thibert M. Can Education Really Change Behavior? Designing Effective Sex Education Programs for HIV Prevention. Princeton: Woodrow Wilson School, Princeton University; 2015.

  52. 52.

    The Behavioural Insights Team. Accessed 1 Dec 2016.

  53. 53.

    Social and Behavioral Sciences Team. Accessed 1 Dec 2016.

  54. 54.

    NSW Government: Premier & Practice. Behavioural Insights Community of Practice. Accessed 1 Dec 2016, 2016.

    Google Scholar 

  55. 55.

    Milat AJ, King L, Bauman AE, Redman S. The concept of scalability: increasing the scale and potential adoption of health promotion interventions into policy and practice. Health Promot Int. 2013;28(3):285–98.

    Article  Google Scholar 

Download references


The authors thank members of the Chagas Disease Working Group in Arequipa who contributed to and facilitated this work, including Fernando Malaga, Andy Catacora, Karina Oppe, and Juan Cornejo del Carpio. We also acknowledge support from Claudia Arevalo and Jenni Peterson. We gratefully acknowledge the invaluable contributions of the Ministerio de Salud del Perú (MINSA), the Dirección General de Salud de las Personas (DGSP), the Estrategia Sanitaria Nacional de Prevención y Control de Enfermedades Metaxenicas y Otras Transmitidas por Vectores (ESNPCEMOTVS), the Dirección General de Salud Ambiental (DIGESA), the Gobierno Regional de Arequipa, the Gerencia Regional de Salud de Arequipa (GRSA), the Pan American Health Organization (PAHO/OPS) and the Canadian International Development Agency (CIDA).


This work was supported by the National Institutes of Health [R01-HD075869]. The funder had no role in the design, execution, or analysis of the study, nor in the preparation or approval of manuscripts related to the study.

Author information




AMB, MZL, RCN, CN, JRB, and VPS all contributed to the conception and design of the study and the interpretation of data. MM, ATV, JM, LMR, and KBM contributed to the design of the work, and the acquisition and analysis of data. AMB drafted the work. All authors substantively revised the work, have approved the submitted version, and have agreed both to be personally accountable for the author’s own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.

Corresponding author

Correspondence to Alison M. Buttenheim.

Ethics declarations

Ethics approval and consent to participate

Ethical approval for the trial discussed in this paper and the formative work underlying it was obtained from the Institutional Review Boards of the Universidad Peruana Cayetano Heredia, the University of Pennsylvania and Tulane University. Informed consent for participation in the study of the vector control campaign was waived by the three Institutional Review Boards.

Consent for publication

Not applicable.

Competing interests

Alison M. Buttenheim was an Associate Editor of BMC Public Health at the time of the manuscripts initial submission and acceptance. All other authors declare that they have no competing interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

A pre-print version of this manuscript was archived at SocArXiv on May 4, 2018 under a CC-By Attribution license 4.0 International, doi:

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Buttenheim, A.M., Levy, M.Z., Castillo-Neyra, R. et al. A behavioral design approach to improving a Chagas disease vector control campaign in Peru. BMC Public Health 19, 1272 (2019).

Download citation


  • Vector control
  • Behavioral economics
  • Public health
  • Intervention design
  • Chagas disease
  • Peru